Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-01

AUTHORS

Hakuei Yamashita, Hiroo Yoda, Noriomi Kuroki, Michiko Kuwabara, Yuji Odagaki, Tetsushi Kazawa, Ryoichi Toyoshima, Taeko Maruki

ABSTRACT

RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance. OBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ. METHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (μU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR > 1.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed. RESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study. CONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance. More... »

PAGES

1-9

References to SciGraph publications

  • 2003-11. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses in PSYCHOPHARMACOLOGY
  • 1997-09. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2005. Comparison of the Effects of Valsartan and Felodipine on Plasma Leptin and Insulin Sensitivity in Hypertensive Obese Patients in HYPERTENSION RESEARCH
  • 1985-07. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man in DIABETOLOGIA
  • 2009-01. The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension in HYPERTENSION RESEARCH
  • 2010-06. Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis in NEUROPSYCHOPHARMACOLOGY
  • 2009-02. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients in HYPERTENSION RESEARCH
  • 1999-09. Olanzapine in CLINICAL PHARMACOKINETICS
  • 2008-04. Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes: A Post-Hoc Analysis of the Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study in HYPERTENSION RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9

    DOI

    http://dx.doi.org/10.1007/s00213-010-2002-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048620444

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20820759


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin II Type 1 Receptor Blockers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antipsychotic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzimidazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzoates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzodiazepines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperinsulinism", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin Resistance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Olanzapine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptor, Angiotensin, Type 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Schizophrenia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Telmisartan", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tetrazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Valine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Valsartan", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamashita", 
            "givenName": "Hakuei", 
            "id": "sg:person.01372434234.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372434234.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoda", 
            "givenName": "Hiroo", 
            "id": "sg:person.0601220174.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601220174.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "National Center of Neurology and Psychiatry", 
              "id": "https://www.grid.ac/institutes/grid.419280.6", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kuroki", 
            "givenName": "Noriomi", 
            "id": "sg:person.01033241245.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033241245.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kuwabara", 
            "givenName": "Michiko", 
            "id": "sg:person.0765726277.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765726277.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Odagaki", 
            "givenName": "Yuji", 
            "id": "sg:person.01017742563.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017742563.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kazawa", 
            "givenName": "Tetsushi", 
            "id": "sg:person.012046357121.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012046357121.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Toyoshima", 
            "givenName": "Ryoichi", 
            "id": "sg:person.01066055763.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066055763.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maruki", 
            "givenName": "Taeko", 
            "id": "sg:person.0647333374.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647333374.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1056/nejmoa1001121", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001214885"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.diabres.2003.11.024", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005751248"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/hr.2008.31", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009767304", 
              "https://doi.org/10.1038/hr.2008.31"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012616091"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012616091"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1291/hypres.28.209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013625707", 
              "https://doi.org/10.1291/hypres.28.209"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/hr.2008.18", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015339541", 
              "https://doi.org/10.1038/hr.2008.18"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1074/jbc.m103241200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016692557"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(09)60619-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018122882"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.cir.0000024416.33113.0a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018363188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-003-1529-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018877776", 
              "https://doi.org/10.1007/s00213-003-1529-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archpsyc.62.1.19", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020046671"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.metabol.2006.04.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021574484"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1592/phco.22.11.841.33629", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021839201"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.diabres.2004.11.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025133185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000203000103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025373687"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000203000103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025373687"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(08)61764-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026964433"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.pnpbp.2007.08.022", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028964604"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1291/hypres.31.657", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029252385", 
              "https://doi.org/10.1291/hypres.31.657"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.cir.0000127955.36250.65", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029448060"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s1092852900026663", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031913866"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmcp0909392", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032081491"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.clinbiochem.2007.05.009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032335098"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033847339", 
              "https://doi.org/10.1038/npp.2010.21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033847339", 
              "https://doi.org/10.1038/npp.2010.21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(04)16451-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034317205"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/oxfordjournals.epirev.a017978", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035014475"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199937030-00001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035394480", 
              "https://doi.org/10.2165/00003088-199937030-00001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.atv.11.1.80", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036167222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(07)60669-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037202954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archpsyc.59.4.337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039319227"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.hyp.0000125142.41703.64", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040225085"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.hyp.0000125142.41703.64", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040225085"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.metabol.2006.04.013", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045685675"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa051688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047149354"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa051688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047149354"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.euroneuro.2006.09.005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047595046"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/00498250500158175", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048048010"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000002800401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049009789"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000002800401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049009789"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archinte.161.11.1413", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051518645"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.eurpsy.2005.05.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052612314"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002280050317", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053532490", 
              "https://doi.org/10.1007/s002280050317"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1176/appi.ajp.160.2.284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063495101"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.37.12.1595", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070735404"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diabetes.37.12.1595", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070741229"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.22.9.1462", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070748909"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4088/jcp.v62n0204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072207842"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4088/jcp.v67n0408", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072209452"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074525287", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077201408", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/central/cn-00563258", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1077201408"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078839834", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/oxfordjournals.aje.a116768", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082754453"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-01", 
        "datePublishedReg": "2011-01-01", 
        "description": "RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance.\nOBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ.\nMETHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (\u03bcU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR\u2009>\u20091.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed.\nRESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study.\nCONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s00213-010-2002-9", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1085440", 
            "issn": [
              "0033-3158", 
              "1432-2072"
            ], 
            "name": "Psychopharmacology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "213"
          }
        ], 
        "name": "Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine", 
        "pagination": "1-9", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e79e72e369ebe8f66e5a5e0fcc8efe8e21d25dfa979c8412def8905cd8d4d6ae"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20820759"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "7608025"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00213-010-2002-9"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048620444"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00213-010-2002-9", 
          "https://app.dimensions.ai/details/publication/pub.1048620444"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T10:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000351_0000000351/records_43264_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.1007%2Fs00213-010-2002-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    355 TRIPLES      21 PREDICATES      97 URIs      39 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00213-010-2002-9 schema:about N1786ae31695043b3b3dff4c5156119ae
    2 N2a36f796eb554314bce93dc641241c9e
    3 N3aaa3ede87964f6e9056c8a6d7693cd4
    4 N3c1f152bb8e54db9bdb672f6e5373c66
    5 N3fbe06dee88241da8ad4f1cdc0d6fee9
    6 N42ed563ecc3644cf9956575d5b20ec03
    7 N6993e2150c384789ab3db727ccb64b85
    8 N7420d4e384504805bef8e069a99a5139
    9 N985b53fac27347148ccbaf59f00fdd85
    10 Nba3c9d8f8db44fa2ad955263675f7b5b
    11 Nc52ee46af08a4e2aac88c7cb41a65cbb
    12 Ncac50275faed46478f647397789eb250
    13 Ncf7f7bada87249c4b249662f7f323442
    14 Nd05076be3491475d8abe1ab264e5d7db
    15 Nd10f1106f3094c45a70046f1e300a151
    16 Ne8f830db725640e3ab35a4ea83ff2005
    17 Nee9bc84792e048edab42cb49821b2845
    18 Nf87a99ac098e4b3e9cf86d6fd6425e9c
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 schema:author N449f7072ee6a4da5b1515265267efe03
    22 schema:citation sg:pub.10.1007/bf00280883
    23 sg:pub.10.1007/s00213-003-1529-4
    24 sg:pub.10.1007/s002280050317
    25 sg:pub.10.1038/hr.2008.18
    26 sg:pub.10.1038/hr.2008.31
    27 sg:pub.10.1038/npp.2010.21
    28 sg:pub.10.1291/hypres.28.209
    29 sg:pub.10.1291/hypres.31.657
    30 sg:pub.10.2165/00003088-199937030-00001
    31 https://app.dimensions.ai/details/publication/pub.1074525287
    32 https://app.dimensions.ai/details/publication/pub.1077201408
    33 https://app.dimensions.ai/details/publication/pub.1078839834
    34 https://doi.org/10.1001/archinte.161.11.1413
    35 https://doi.org/10.1001/archpsyc.59.4.337
    36 https://doi.org/10.1001/archpsyc.62.1.19
    37 https://doi.org/10.1002/central/cn-00563258
    38 https://doi.org/10.1016/j.clinbiochem.2007.05.009
    39 https://doi.org/10.1016/j.diabres.2003.11.024
    40 https://doi.org/10.1016/j.diabres.2004.11.001
    41 https://doi.org/10.1016/j.euroneuro.2006.09.005
    42 https://doi.org/10.1016/j.eurpsy.2005.05.011
    43 https://doi.org/10.1016/j.metabol.2006.04.011
    44 https://doi.org/10.1016/j.metabol.2006.04.013
    45 https://doi.org/10.1016/j.pnpbp.2007.08.022
    46 https://doi.org/10.1016/s0140-6736(04)16451-9
    47 https://doi.org/10.1016/s0140-6736(07)60669-2
    48 https://doi.org/10.1016/s0140-6736(08)61764-x
    49 https://doi.org/10.1016/s0140-6736(09)60619-x
    50 https://doi.org/10.1017/s1092852900026663
    51 https://doi.org/10.1056/nejmcp0909392
    52 https://doi.org/10.1056/nejmoa051688
    53 https://doi.org/10.1056/nejmoa1001121
    54 https://doi.org/10.1074/jbc.m103241200
    55 https://doi.org/10.1080/00498250500158175
    56 https://doi.org/10.1093/oxfordjournals.aje.a116768
    57 https://doi.org/10.1093/oxfordjournals.epirev.a017978
    58 https://doi.org/10.1097/hjh.0b013e3281fc975a
    59 https://doi.org/10.1161/01.atv.11.1.80
    60 https://doi.org/10.1161/01.cir.0000024416.33113.0a
    61 https://doi.org/10.1161/01.cir.0000127955.36250.65
    62 https://doi.org/10.1161/01.hyp.0000125142.41703.64
    63 https://doi.org/10.1176/appi.ajp.160.2.284
    64 https://doi.org/10.1177/147323000002800401
    65 https://doi.org/10.1177/147323000203000103
    66 https://doi.org/10.1592/phco.22.11.841.33629
    67 https://doi.org/10.2337/diab.37.12.1595
    68 https://doi.org/10.2337/diabetes.37.12.1595
    69 https://doi.org/10.2337/diacare.22.9.1462
    70 https://doi.org/10.4088/jcp.v62n0204
    71 https://doi.org/10.4088/jcp.v67n0408
    72 schema:datePublished 2011-01
    73 schema:datePublishedReg 2011-01-01
    74 schema:description RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance. OBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ. METHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (μU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR > 1.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed. RESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study. CONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance.
    75 schema:genre research_article
    76 schema:inLanguage en
    77 schema:isAccessibleForFree false
    78 schema:isPartOf N10840512a80b42ab81f9a62afa213ea3
    79 N9119e395562e4271af2415cd129eb76f
    80 sg:journal.1085440
    81 schema:name Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine
    82 schema:pagination 1-9
    83 schema:productId N00d6436c1b1a4861b5f9645b4c8b0c0e
    84 N55d31bda54aa4af8a6eee2ab8f75348d
    85 Na52d0a400c25483a9e870a7fd7741c2c
    86 Nc550581905b64ac5a812ad1f4282d285
    87 Nec1a26f562fa4dcdb706b03b12594deb
    88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048620444
    89 https://doi.org/10.1007/s00213-010-2002-9
    90 schema:sdDatePublished 2019-04-11T10:55
    91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    92 schema:sdPublisher Nc0b6c751ff2a414bb2af6e92a1140813
    93 schema:url http://link.springer.com/10.1007%2Fs00213-010-2002-9
    94 sgo:license sg:explorer/license/
    95 sgo:sdDataset articles
    96 rdf:type schema:ScholarlyArticle
    97 N00d6436c1b1a4861b5f9645b4c8b0c0e schema:name nlm_unique_id
    98 schema:value 7608025
    99 rdf:type schema:PropertyValue
    100 N10840512a80b42ab81f9a62afa213ea3 schema:issueNumber 1
    101 rdf:type schema:PublicationIssue
    102 N12bc151fb4a04a7a993bc8cc8cafacf3 rdf:first sg:person.012046357121.83
    103 rdf:rest N5a218a961ca04712aaf98bc3f8137d2b
    104 N1682b601638d4809899708ebac42f8ee schema:name Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    105 rdf:type schema:Organization
    106 N1786ae31695043b3b3dff4c5156119ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Benzodiazepines
    108 rdf:type schema:DefinedTerm
    109 N2a36f796eb554314bce93dc641241c9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Insulin Resistance
    111 rdf:type schema:DefinedTerm
    112 N3aaa3ede87964f6e9056c8a6d7693cd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Receptor, Angiotensin, Type 1
    114 rdf:type schema:DefinedTerm
    115 N3c1f152bb8e54db9bdb672f6e5373c66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Benzoates
    117 rdf:type schema:DefinedTerm
    118 N3fbe06dee88241da8ad4f1cdc0d6fee9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Valine
    120 rdf:type schema:DefinedTerm
    121 N42ed563ecc3644cf9956575d5b20ec03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Valsartan
    123 rdf:type schema:DefinedTerm
    124 N449f7072ee6a4da5b1515265267efe03 rdf:first sg:person.01372434234.34
    125 rdf:rest Neba345bace5240cabe86f59e935fc4f7
    126 N55d31bda54aa4af8a6eee2ab8f75348d schema:name pubmed_id
    127 schema:value 20820759
    128 rdf:type schema:PropertyValue
    129 N5a218a961ca04712aaf98bc3f8137d2b rdf:first sg:person.01066055763.17
    130 rdf:rest N7bfddc6eadbe40feb770ebea37541012
    131 N6993e2150c384789ab3db727ccb64b85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Female
    133 rdf:type schema:DefinedTerm
    134 N7420d4e384504805bef8e069a99a5139 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Benzimidazoles
    136 rdf:type schema:DefinedTerm
    137 N7bfddc6eadbe40feb770ebea37541012 rdf:first sg:person.0647333374.52
    138 rdf:rest rdf:nil
    139 N9119e395562e4271af2415cd129eb76f schema:volumeNumber 213
    140 rdf:type schema:PublicationVolume
    141 N985b53fac27347148ccbaf59f00fdd85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Humans
    143 rdf:type schema:DefinedTerm
    144 Na1b467f6dd594c95a17388738533e96d rdf:first sg:person.01017742563.44
    145 rdf:rest N12bc151fb4a04a7a993bc8cc8cafacf3
    146 Na52d0a400c25483a9e870a7fd7741c2c schema:name doi
    147 schema:value 10.1007/s00213-010-2002-9
    148 rdf:type schema:PropertyValue
    149 Na5af752b049247939d9f7c4e5ed0c5b0 rdf:first sg:person.0765726277.27
    150 rdf:rest Na1b467f6dd594c95a17388738533e96d
    151 Nb1594d31d06c45f6aad1c241a698a31d schema:name Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    152 rdf:type schema:Organization
    153 Nba3c9d8f8db44fa2ad955263675f7b5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Middle Aged
    155 rdf:type schema:DefinedTerm
    156 Nc0b6c751ff2a414bb2af6e92a1140813 schema:name Springer Nature - SN SciGraph project
    157 rdf:type schema:Organization
    158 Nc52ee46af08a4e2aac88c7cb41a65cbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Olanzapine
    160 rdf:type schema:DefinedTerm
    161 Nc550581905b64ac5a812ad1f4282d285 schema:name readcube_id
    162 schema:value e79e72e369ebe8f66e5a5e0fcc8efe8e21d25dfa979c8412def8905cd8d4d6ae
    163 rdf:type schema:PropertyValue
    164 Ncac50275faed46478f647397789eb250 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Angiotensin II Type 1 Receptor Blockers
    166 rdf:type schema:DefinedTerm
    167 Nccb20aa733264203a7459b3f4f4f1098 rdf:first sg:person.01033241245.91
    168 rdf:rest Na5af752b049247939d9f7c4e5ed0c5b0
    169 Ncf7f7bada87249c4b249662f7f323442 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Hyperinsulinism
    171 rdf:type schema:DefinedTerm
    172 Nd05076be3491475d8abe1ab264e5d7db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Antipsychotic Agents
    174 rdf:type schema:DefinedTerm
    175 Nd10f1106f3094c45a70046f1e300a151 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Schizophrenia
    177 rdf:type schema:DefinedTerm
    178 Ne8f830db725640e3ab35a4ea83ff2005 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Telmisartan
    180 rdf:type schema:DefinedTerm
    181 Neba345bace5240cabe86f59e935fc4f7 rdf:first sg:person.0601220174.42
    182 rdf:rest Nccb20aa733264203a7459b3f4f4f1098
    183 Nec1a26f562fa4dcdb706b03b12594deb schema:name dimensions_id
    184 schema:value pub.1048620444
    185 rdf:type schema:PropertyValue
    186 Nee9bc84792e048edab42cb49821b2845 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Male
    188 rdf:type schema:DefinedTerm
    189 Nf87a99ac098e4b3e9cf86d6fd6425e9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Tetrazoles
    191 rdf:type schema:DefinedTerm
    192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    193 schema:name Medical and Health Sciences
    194 rdf:type schema:DefinedTerm
    195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    196 schema:name Clinical Sciences
    197 rdf:type schema:DefinedTerm
    198 sg:journal.1085440 schema:issn 0033-3158
    199 1432-2072
    200 schema:name Psychopharmacology
    201 rdf:type schema:Periodical
    202 sg:person.01017742563.44 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    203 schema:familyName Odagaki
    204 schema:givenName Yuji
    205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017742563.44
    206 rdf:type schema:Person
    207 sg:person.01033241245.91 schema:affiliation https://www.grid.ac/institutes/grid.419280.6
    208 schema:familyName Kuroki
    209 schema:givenName Noriomi
    210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033241245.91
    211 rdf:type schema:Person
    212 sg:person.01066055763.17 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    213 schema:familyName Toyoshima
    214 schema:givenName Ryoichi
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066055763.17
    216 rdf:type schema:Person
    217 sg:person.012046357121.83 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    218 schema:familyName Kazawa
    219 schema:givenName Tetsushi
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012046357121.83
    221 rdf:type schema:Person
    222 sg:person.01372434234.34 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    223 schema:familyName Yamashita
    224 schema:givenName Hakuei
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372434234.34
    226 rdf:type schema:Person
    227 sg:person.0601220174.42 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    228 schema:familyName Yoda
    229 schema:givenName Hiroo
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601220174.42
    231 rdf:type schema:Person
    232 sg:person.0647333374.52 schema:affiliation Nb1594d31d06c45f6aad1c241a698a31d
    233 schema:familyName Maruki
    234 schema:givenName Taeko
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647333374.52
    236 rdf:type schema:Person
    237 sg:person.0765726277.27 schema:affiliation N1682b601638d4809899708ebac42f8ee
    238 schema:familyName Kuwabara
    239 schema:givenName Michiko
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765726277.27
    241 rdf:type schema:Person
    242 sg:pub.10.1007/bf00280883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027902786
    243 https://doi.org/10.1007/bf00280883
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1007/s00213-003-1529-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018877776
    246 https://doi.org/10.1007/s00213-003-1529-4
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1007/s002280050317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053532490
    249 https://doi.org/10.1007/s002280050317
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/hr.2008.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015339541
    252 https://doi.org/10.1038/hr.2008.18
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/hr.2008.31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009767304
    255 https://doi.org/10.1038/hr.2008.31
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/npp.2010.21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033847339
    258 https://doi.org/10.1038/npp.2010.21
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1291/hypres.28.209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013625707
    261 https://doi.org/10.1291/hypres.28.209
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1291/hypres.31.657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029252385
    264 https://doi.org/10.1291/hypres.31.657
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.2165/00003088-199937030-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035394480
    267 https://doi.org/10.2165/00003088-199937030-00001
    268 rdf:type schema:CreativeWork
    269 https://app.dimensions.ai/details/publication/pub.1074525287 schema:CreativeWork
    270 https://app.dimensions.ai/details/publication/pub.1077201408 schema:CreativeWork
    271 https://app.dimensions.ai/details/publication/pub.1078839834 schema:CreativeWork
    272 https://doi.org/10.1001/archinte.161.11.1413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051518645
    273 rdf:type schema:CreativeWork
    274 https://doi.org/10.1001/archpsyc.59.4.337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039319227
    275 rdf:type schema:CreativeWork
    276 https://doi.org/10.1001/archpsyc.62.1.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020046671
    277 rdf:type schema:CreativeWork
    278 https://doi.org/10.1002/central/cn-00563258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077201408
    279 rdf:type schema:CreativeWork
    280 https://doi.org/10.1016/j.clinbiochem.2007.05.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032335098
    281 rdf:type schema:CreativeWork
    282 https://doi.org/10.1016/j.diabres.2003.11.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005751248
    283 rdf:type schema:CreativeWork
    284 https://doi.org/10.1016/j.diabres.2004.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025133185
    285 rdf:type schema:CreativeWork
    286 https://doi.org/10.1016/j.euroneuro.2006.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047595046
    287 rdf:type schema:CreativeWork
    288 https://doi.org/10.1016/j.eurpsy.2005.05.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052612314
    289 rdf:type schema:CreativeWork
    290 https://doi.org/10.1016/j.metabol.2006.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021574484
    291 rdf:type schema:CreativeWork
    292 https://doi.org/10.1016/j.metabol.2006.04.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045685675
    293 rdf:type schema:CreativeWork
    294 https://doi.org/10.1016/j.pnpbp.2007.08.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028964604
    295 rdf:type schema:CreativeWork
    296 https://doi.org/10.1016/s0140-6736(04)16451-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034317205
    297 rdf:type schema:CreativeWork
    298 https://doi.org/10.1016/s0140-6736(07)60669-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037202954
    299 rdf:type schema:CreativeWork
    300 https://doi.org/10.1016/s0140-6736(08)61764-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026964433
    301 rdf:type schema:CreativeWork
    302 https://doi.org/10.1016/s0140-6736(09)60619-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018122882
    303 rdf:type schema:CreativeWork
    304 https://doi.org/10.1017/s1092852900026663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031913866
    305 rdf:type schema:CreativeWork
    306 https://doi.org/10.1056/nejmcp0909392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032081491
    307 rdf:type schema:CreativeWork
    308 https://doi.org/10.1056/nejmoa051688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047149354
    309 rdf:type schema:CreativeWork
    310 https://doi.org/10.1056/nejmoa1001121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001214885
    311 rdf:type schema:CreativeWork
    312 https://doi.org/10.1074/jbc.m103241200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016692557
    313 rdf:type schema:CreativeWork
    314 https://doi.org/10.1080/00498250500158175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048048010
    315 rdf:type schema:CreativeWork
    316 https://doi.org/10.1093/oxfordjournals.aje.a116768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082754453
    317 rdf:type schema:CreativeWork
    318 https://doi.org/10.1093/oxfordjournals.epirev.a017978 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035014475
    319 rdf:type schema:CreativeWork
    320 https://doi.org/10.1097/hjh.0b013e3281fc975a schema:sameAs https://app.dimensions.ai/details/publication/pub.1012616091
    321 rdf:type schema:CreativeWork
    322 https://doi.org/10.1161/01.atv.11.1.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036167222
    323 rdf:type schema:CreativeWork
    324 https://doi.org/10.1161/01.cir.0000024416.33113.0a schema:sameAs https://app.dimensions.ai/details/publication/pub.1018363188
    325 rdf:type schema:CreativeWork
    326 https://doi.org/10.1161/01.cir.0000127955.36250.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029448060
    327 rdf:type schema:CreativeWork
    328 https://doi.org/10.1161/01.hyp.0000125142.41703.64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040225085
    329 rdf:type schema:CreativeWork
    330 https://doi.org/10.1176/appi.ajp.160.2.284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063495101
    331 rdf:type schema:CreativeWork
    332 https://doi.org/10.1177/147323000002800401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049009789
    333 rdf:type schema:CreativeWork
    334 https://doi.org/10.1177/147323000203000103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025373687
    335 rdf:type schema:CreativeWork
    336 https://doi.org/10.1592/phco.22.11.841.33629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021839201
    337 rdf:type schema:CreativeWork
    338 https://doi.org/10.2337/diab.37.12.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070735404
    339 rdf:type schema:CreativeWork
    340 https://doi.org/10.2337/diabetes.37.12.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070741229
    341 rdf:type schema:CreativeWork
    342 https://doi.org/10.2337/diacare.22.9.1462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070748909
    343 rdf:type schema:CreativeWork
    344 https://doi.org/10.4088/jcp.v62n0204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072207842
    345 rdf:type schema:CreativeWork
    346 https://doi.org/10.4088/jcp.v67n0408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072209452
    347 rdf:type schema:CreativeWork
    348 https://www.grid.ac/institutes/grid.410802.f schema:alternateName Saitama Medical University
    349 schema:name Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    350 Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    351 rdf:type schema:Organization
    352 https://www.grid.ac/institutes/grid.419280.6 schema:alternateName National Center of Neurology and Psychiatry
    353 schema:name Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    354 Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan
    355 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...